Details for New Drug Application (NDA): 013378
✉ Email this page to a colleague
NDA 013378 describes DYMELOR, which is a drug marketed by Lilly and is included in one NDA. Additional details are available on the DYMELOR profile page.
The generic ingredient in DYMELOR is acetohexamide. There are six drug master file entries for this compound. Additional details are available on the acetohexamide profile page.
The generic ingredient in DYMELOR is acetohexamide. There are six drug master file entries for this compound. Additional details are available on the acetohexamide profile page.
Summary for 013378
| Tradename: | DYMELOR |
| Applicant: | Lilly |
| Ingredient: | acetohexamide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 013378
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 250MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
